We develop and validate melanoma patient-derived organoids. It aims to accurately replicate the tumor microenvironment, study immune cell interactions, and assess therapeutic responses, particularly to immunotherapies. We're trying to advance unde
Bu içeriğe erişmek için giriş yapın veya ücretsiz denemenizi başlatın